3Myounga H,Hongb SD,Kima YY,et al.Evaluation of the antitumor and anti angiogenic effect of paclitaxel and thalidomide on the xenona nsplanted oral squamous cell carcinoma[J].Cancer Letters,2001,163(2):191-200. 被引量：1
7Weber DM,Rankin K,Gavino M,et al.Thalidomide with dexamethasone for resistant multiple myeloma[J].Blood,2000,96(5):719. 被引量：1
二级参考文献4
1Fisher RI, Gaynor ER, Dahlberg S, et al. Comparison of a standard regimen(CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkins. N Engl J Med, 1993, 328(14): 1002 - 1006. 被引量：1
2Moskowitz CH, Nimer SD, Glassman JR, et al. The International Prognostic Index predicts for outcome following ASCT in patients with relapsed and primary refractory intermediate-grade lymphoma. Bone Marrow Transplant, 1999, 23(6): 561 - 567. 被引量：1
3McCoy AG,Smith EP, Atkinson ME, et al. A novel preparative regimen for autologous transplant in non-Hodgkin' s lymphoma: long-term experience with etoposide and thiotepa. Bone Marrow Transplant, 2004,33(1): 19 -24. 被引量：1
4Moskowitz CH, Bertino JR, Glassman JR, et al. Ifosfamide, carboplatin,and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-Cell mobilization regimen for transplant-eligible patients with non-Hodgkin' s lymphoma. J Clin Oncol, 1999, 17( 12): 3776 - 3785. 被引量：1
